₹80.75
+₹3.84 (+4.99%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹250 Cr
P/E
59.91
ROE
2.64%
ROCE
5.20%
About Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals in the manufacturing and trading of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemi'cals.
Founded
1990
CEO
Mihir R Ghatalia
Employees
0
HQ
Mumbai, India
About Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals in the manufacturing and trading of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemi'cals.
Founded:1990
CEO:Mihir R Ghatalia
Employees:0
HQ:Mumbai, India
Finished Products
1Sales
₹869.36Cr2Commission received
₹0.20CrRaw Materials
1Purchases
₹464.66Cr2Finished Goods Purchases
₹381.23Cr3Direct Expenses
₹14.73CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹100
52W Low
₹50
Volume205.19K
Avg VolumeN/A
Beta1.45
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
59.91x
Valuation
P/B Ratio
1.50x
Valuation
EPS
₹1.35
Valuation
Dividend Yield
0.00%
Valuation
ROE
2.64%
Profitability
ROCE
5.20%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading & Manufacturing of Drugs &Revenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.33x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
4.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.